Gallium (Lantheus Medical Imaging, Inc.)


Welcome to the PulseAid listing for the Gallium drug offered from Lantheus Medical Imaging, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Lantheus Medical Imaging, Inc.
NON-PROPRIETARY NAME: GALLIUM CITRATE GA-67
SUBSTANCE NAME: GALLIUM CITRATE GA-67
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1976-05-19
END MARKETING DATE: 0000-00-00


Gallium HUMAN PRESCRIPTION DRUG Details:

Item DescriptionGallium from Lantheus Medical Imaging, Inc.
LABELER NAME: Lantheus Medical Imaging, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 2(mCi/mL)
START MARKETING DATE: 1976-05-19
END MARKETING DATE: 0000-00-00
PRODUCT ID: 11994-121_96bce1f0-1255-460e-8839-46d494411921
PRODUCT NDC: 11994-121
APPLICATION NUMBER: NDA017478

Other GALLIUM CITRATE GA-67 Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Lantheus Medical Imaging, Inc.Gallium